Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer

BACKGROUND: Immune checkpoint inhibitors (ICI) improve clinical outcomes in triple-negative breast cancer (TNBC) patients. However, a subset of patients does not respond to treatment. Biomarkers that show ICI predictive potential in other solid tumors, such as levels of PD-L1 and the tumor mutationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ensenyat-Mendez, Miquel, Orozco, Javier I. J., Llinàs-Arias, Pere, Íñiguez-Muñoz, Sandra, Baker, Jennifer L., Salomon, Matthew P., Martí, Mercè, DiNome, Maggie L., Cortés, Javier, Marzese, Diego M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333210/
https://www.ncbi.nlm.nih.gov/pubmed/37430006
http://dx.doi.org/10.1038/s43856-023-00311-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333210/
https://www.ncbi.nlm.nih.gov/pubmed/37430006
http://dx.doi.org/10.1038/s43856-023-00311-y

Ejemplares similares